Correction: Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials
Andrew R. DiNardo, Wilbert Sabiiti, Stephen H. Gillespie, Sophia B. Georghiou, Norbert Heinrich, Norbert Hittel, Sami Taghlabi, Danna Carrero Longlax, et al. (18 authors)
Frontiers in Antibiotics · 2026-03
Abstract
[This corrects the article DOI: 10.3389/frabi.2025.1570989.].
MeSH terms
- Medicine
- Tuberculosis
- Internal medicine
- Drug
- Clinical trial
- Disease
- Inclusion (mineral)
- Drug trial
- Intensive care medicine
- Pharmacotherapy
- MEDLINE